Patent · US Active

CD131 binding proteins and uses thereof

US11840573B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

CSL LIMITED · AU

Inventors

Catherine OWCZAREK · Melbourne, AU
Con Panousis · Melbourne, AU
Nicholas Stuart Wilson · Melbourne, AU
Matthew HARDY · Whittlesea, AU
Kirsten Mae Edwards · Melbourne, AU
Veronika Rayzman · Melbourne, AU

Key dates

Filing date	Nov 20, 2020
Grant date	Dec 12, 2023
Priority date	—
Expiry date	Nov 14, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70596
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.